MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Humana Inc

Slēgts

SektorsVeselības aprūpe

267.51 1.5

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

257.72

Max

267.73

Galvenie mērījumi

By Trading Economics

Ienākumi

-1.2B

-683M

Pārdošana

-184M

29B

P/E

Sektora vidējais

24.665

57.333

EPS

-2.16

Dividenžu ienesīgums

1.34

Peļņas marža

-2.338

Darbinieki

65,680

EBITDA

-1.3B

-303M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+12.01% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.34%

2.63%

Nākamais dividenžu datums

2025. g. 25. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-6B

30B

Iepriekšējā atvēršanas cena

266.01

Iepriekšējā slēgšanas cena

267.51

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Humana Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. apr. 16:14 UTC

Galvenie tirgus virzītāji

Humana Stock Caught in UnitedHealth's Downslide from Medicare Scare

2025. g. 7. apr. 21:36 UTC

Galvenie tirgus virzītāji

Medicare Insurer Shares Rise on Plans for Higher Payment Rates

2025. g. 17. apr. 20:34 UTC

Peļņas

UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com

2025. g. 17. apr. 18:24 UTC

Peļņas

UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com

2025. g. 17. apr. 13:38 UTC

Peļņas

UnitedHealth Stock Sinks 18% After Earnings. Medicare Advantage Is an Issue. -- Barrons.com

2025. g. 17. apr. 11:20 UTC

Peļņas

UnitedHealth Stock Sinks 20% on Earnings Miss and Guidance Cut. Medicare Advantage Is an Issue. -- Barrons.com

2025. g. 17. apr. 10:46 UTC

Peļņas

UnitedHealth Stock Sinks 19% on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 17. apr. 10:40 UTC

Peļņas

UnitedHealth Stock Sinks 19% on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 17. apr. 10:15 UTC

Peļņas

UnitedHealth Stock Sinks on Earnings Miss and Guidance Cut -- Barrons.com

2025. g. 7. apr. 22:18 UTC

Top Ziņas

Health Insurer Stocks Jump After Medicare Boosts Payment Rates -- Barrons.com

2025. g. 7. apr. 20:15 UTC

Top Ziņas

Private Medicare Plans to Get Big Payment Boost From Trump Administration -- WSJ

2025. g. 21. febr. 18:22 UTC

Top Ziņas

It's No Longer Business as Usual for UnitedHealth, or the Entire Healthcare Industry -- Heard on the Street -- WSJ

2025. g. 12. febr. 15:24 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 13:58 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 12:16 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 12. febr. 11:55 UTC

Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 11. febr. 21:30 UTC

Top Ziņas

CVS Health Stock Is Making a Comeback. Earnings Are the Next Hurdle. -- Barrons.com

2025. g. 11. febr. 17:32 UTC

Top Ziņas

Humana Stock Slides Despite Solid Quarter Amid Weak Forecast -- Barrons.com

2025. g. 11. febr. 17:05 UTC

Top Ziņas

Humana Stock Is Rising. Its Quarter Was Better Than Feared. -- Barrons.com

2025. g. 11. febr. 09:57 UTC

Peļņas
Karstas akcijas

Stocks to Watch Tuesday: Cleveland-Cliffs, Super Micro Computer, Kering -- WSJ

2025. g. 29. janv. 21:06 UTC

Peļņas

CVS and Other Healthcare Stocks Are Soaring. Why the Sector Is No Longer Sick. -- Barrons.com

2025. g. 23. janv. 14:54 UTC

Peļņas

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

2025. g. 23. janv. 12:35 UTC

Peļņas

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

2025. g. 16. janv. 21:56 UTC

Peļņas

UnitedHealth CEO Defends Company As Stock Sinks on Earnings -- Barrons.com

2025. g. 16. janv. 17:29 UTC

Peļņas

Healthcare Stocks Fall After UnitedHealth Posts Higher Medical Costs -- WSJ

2025. g. 16. janv. 14:00 UTC

Peļņas

UnitedHealth's Earnings Point to High Medical Costs in 2025. Health Insurer Stocks Sink. -- Barrons.com

2025. g. 13. janv. 05:01 UTC

Top Ziņas

J.P. Morgan Healthcare Conference Kicks Off. The Industry Isn't Well. -- Barrons.com

2024. g. 20. dec. 10:30 UTC

Top Ziņas

How American Health Insurance Got So Infuriating -- Heard on the Street -- WSJ

2024. g. 7. dec. 12:00 UTC

Top Ziņas

Public Anger at UnitedHealth Risks Shifting Winds in Washington and on Wall Street -- Heard on the Street -- WSJ

2024. g. 5. dec. 16:52 UTC

Top Ziņas

Bullet Casings in Murder of UnitedHealth Exec Highlights Public Anger at Insurers -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Humana Inc Prognoze

Cenas mērķis

By TipRanks

12.01% augšup

Prognoze 12 mēnešiem

Vidējais 300 USD  12.01%

Augstākais 348 USD

Zemākais 256 USD

Pamatojoties uz 16 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Humana Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

16 ratings

5

Pirkt

11

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

264.48 / 281.86Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.